The Week -
3 Sep 2015 17:02

When pre-exposure prophylaxis, or PrEP (Truvada) first hit the market, critics were skeptical of the pill's claims that it could keep clients HIV-free if it at the same time it lured people into believing they could have safe sex condom-free. However, 657 clients and more than two years later, it looks like that has, in fact, been the case: Not one person on the pill caught the virus, The New York Times reports. However, critics who suggested the security provided by PrEP -- which is close to 10...
Share this Article
Comment on this Article
Please to comment